会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
    • 识别基因或多肽,其表达与生育力,卵巢功能和/或胎儿/新生儿存活力相关
    • US07858308B2
    • 2010-12-28
    • US11584580
    • 2006-10-23
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao De Magalhaes Rosa
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao De Magalhaes Rosa
    • C12Q1/68C12P19/34A01N43/04
    • C12Q1/6883C12Q2600/158
    • A genetic means of determining whether a female subject produces “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the “pregnancy signature”, also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. Microarrays containing “pregnancy signature” genes or corresponding polypeptides provide another preferred aspect of the invention. Still further, the subject invention can be used to derive animal models, e.g., non-human primate animal models, for the evaluation of the efficacy of putative female fertility treatments.
    • 提供确定女性受试者是否产生“怀孕受精”卵母细胞的遗传手段。 该方法包括检测在源于妊娠合格卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可以用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫性疾病等。 包含“怀孕特征”基因或相应多肽的微阵列提供本发明的另一优选方面。 此外,本发明可以用于衍生动物模型,例如非人灵长类动物模型,以评估推定的女性生育力治疗的功效。
    • 2. 发明申请
    • Identification of genes involved in fertility, ovarian function and/or fetal/newborn viability
    • 识别涉及生育力,卵巢功能和/或胎儿/新生儿生存力的基因
    • US20070054289A1
    • 2007-03-08
    • US11437797
    • 2006-05-22
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao De Magalhaes Rosa
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao De Magalhaes Rosa
    • C12Q1/00C12Q1/68
    • C12Q1/6883C12Q1/6881C12Q2600/158
    • A genetic means of determining whether a female subject produces “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the “pregnancy signature”, also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. Microarrays containing “pregnancy signature” genes or corresponding polypeptides provide another preferred aspect of the invention. Still further, the subject invention can be used to derive animal models, e.g., non-human primate animal models, for the evaluation of the efficacy of putative female fertility treatments. Additionally, an improved RNA amplification protocol is provided herein referred to as the CRL amplification protocol which is suitable for reproducibly amplifying all the RNAs expressed by a cell sample, even when only a few cells are available.
    • 提供确定女性受试者是否产生“怀孕受精”卵母细胞的遗传手段。 该方法包括检测在源于妊娠合格卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可以用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫性疾病等。 包含“怀孕特征”基因或相应多肽的微阵列提供本发明的另一优选方面。 此外,本发明可以用于衍生动物模型,例如非人灵长类动物模型,以评估推定的女性生育力治疗的功效。 此外,本文提供了改进的RNA扩增方案,其被称为CRL扩增方案,其适用于可再现地扩增由细胞样品表达的所有RNA,即使只有少数细胞可用。
    • 3. 发明申请
    • IDENTIFICATION OF GENES OR POLYPEPTIDES THE EXPRESSION OF WHICH CORRELATES TO FERTILITY, OVARIAN FUNCTION AND/OR FETAL/NEWBORN VIABILITY
    • 基因或多肽的鉴定表达与相关性,卵巢功能和/或雌性/新生儿可能性相关的表达
    • US20110244464A1
    • 2011-10-06
    • US12974781
    • 2010-12-21
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao De Rosa
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao De Rosa
    • C12Q1/68
    • C12Q1/6883C12Q2600/158
    • A genetic means of determining whether a female subject produces “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the “pregnancy signature”, also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. Microarrays containing “pregnancy signature” genes or corresponding polypeptides provide another preferred aspect of the invention. Still further, the subject invention can be used to derive animal models, e.g., non-human primate animal models, for the evaluation of the efficacy of putative female fertility treatments.
    • 提供确定女性受试者是否产生“怀孕受精”卵母细胞的遗传手段。 该方法包括检测在源于妊娠合格卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可以用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫性疾病等。 包含“怀孕特征”基因或相应多肽的微阵列提供本发明的另一优选方面。 此外,本发明可以用于衍生动物模型,例如非人灵长类动物模型,以评估推定的女性生育力治疗的功效。
    • 4. 发明申请
    • Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
    • 识别基因或多肽,其表达与生育力,卵巢功能和/或胎儿/新生儿存活力相关
    • US20070238111A1
    • 2007-10-11
    • US11584580
    • 2006-10-23
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao Rosa
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao Rosa
    • C12Q1/68
    • C12Q1/6883C12Q2600/158
    • A genetic means of determining whether a female subject produces “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the “pregnancy signature”, also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. Microarrays containing “pregnancy signature” genes or corresponding polypeptides provide another preferred aspect of the invention. Still further, the subject invention can be used to derive animal models, e.g., non-human primate animal models, for the evaluation of the efficacy of putative female fertility treatments.
    • 提供确定女性受试者是否产生“怀孕受精”卵母细胞的遗传手段。 该方法包括检测在源于妊娠合格卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可以用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫性疾病等。 包含“怀孕特征”基因或相应多肽的微阵列提供本发明的另一优选方面。 此外,本发明可以用于衍生动物模型,例如非人灵长类动物模型,以评估推定的女性生育力治疗的功效。
    • 5. 发明申请
    • Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
    • 识别基因或多肽,其表达与生育力,卵巢功能和/或胎儿/新生儿存活力相关
    • US20060024693A1
    • 2006-02-02
    • US11091883
    • 2005-03-29
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao Rosa
    • Jose CibelliJavier CrosbyEmilio FernandezArif KocabasGuilherme Jordao Rosa
    • C12Q1/68C12N5/06
    • C12Q1/6881C12Q1/6883C12Q2600/158
    • A genetic means of determining whether a female subject produces “pregnancy competent” oocytes is provided. The means comprises detecting the level of expression of one or more genes that are expressed at characteristic levels (upregulated or downregulated) in cumulus cells derived from pregnancy competent oocytes. This characteristic gene expression level, or pattern referred to herein as the “pregnancy signature”, also can be used to identify subjects with underlying conditions that impair or prevent the development of a viable pregnancy, e.g., pre-menopausal condition, other hormonal dysfunction, ovarian dysfunction, ovarian cyst, cancer or other cell proliferation disorder, autoimmune disease and the like. Microarrays containing “pregnancy signature” genes or corresponding polypeptides provide another preferred aspect of the invention. Still further, the subject invention can be used to derive animal models, e.g., non-human primate animal models, for the evaluation of the efficacy of putative female fertility treatments.
    • 提供确定女性受试者是否产生“怀孕受精”卵母细胞的遗传手段。 该方法包括检测在源于妊娠合格卵母细胞的卵丘细胞中以特征水平(上调或下调)表达的一种或多种基因的表达水平。 这种特征性基因表达水平或本文称为“怀孕签名”的模式也可以用于鉴定有潜在病症的受试者,其损害或预防可行妊娠的发展,例如绝经前期,其他激素功能障碍, 卵巢功能障碍,卵巢囊肿,癌症或其他细胞增殖障碍,自身免疫性疾病等。 包含“怀孕特征”基因或相应多肽的微阵列提供本发明的另一优选方面。 此外,本发明可以用于衍生动物模型,例如非人灵长类动物模型,以评估推定的女性生育力治疗的功效。